MindRank Announces First-in-Human Phase 1 Study of MDR-001 in China
(Adnkronos) – SHANGHAI and HANGZHOU, China, June 14, 2023 /PRNewswire/ — MindRank, a clinical stage artificial intelligence (AI)-empowered drug discovery company, announced today that the first healthy volunteer dosed in the Phase 1
